How to treat pancreatic adenocarcinoma in elderly: How far can we go in 2017?

Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, 136, E359, 10.1002/ijc.29210

Jemal, 2010, Cancer statistics 2010, CA Cancer J Clin, 60, 277, 10.3322/caac.20073

Berrino, 2007, Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study, Lancet Oncol, 8, 773, 10.1016/S1470-2045(07)70245-0

Hidalgo, 2010, Pancreatic cancer, N Engl J Med, 362, 1605, 10.1056/NEJMra0901557

Oettle, 2007, Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial, JAMA, 297, 267, 10.1001/jama.297.3.267

Neoptolemos, 2010, Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial, JAMA, 304, 1073, 10.1001/jama.2010.1275

Burris, 1997, Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial, J Clin Oncol, 15, 2403, 10.1200/JCO.1997.15.6.2403

Conroy, 2011, FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer, N Engl J Med, 364, 1817, 10.1056/NEJMoa1011923

Von Hoff, 2013, Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine, N Engl J Med, 369, 1691, 10.1056/NEJMoa1304369

2010

Matsuda, 2009, Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project, Jpn J Clin Oncol, 39, 850, 10.1093/jjco/hyp106

Kamisawa, 1998, Characteristics of pancreatic carcinoma in the elderly, Int J Pancreatol, 24, 31, 10.1007/BF02787528

S.F. Sener, A. Fremgen, H.R. Menck, D.P Winchester, Pancreatic cancer: A report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database, J Am Coll Surg 189 (1–7), 2001, 1999, [ONCOLOGY. Vol. 15 No. 7 July 1].

Niederhuber, 1995, The National Cancer Database report on pancreatic cancer, Cancer, 76, 1671, 10.1002/1097-0142(19951101)76:9<1671::AID-CNCR2820760926>3.0.CO;2-R

Sato, 1997, p53 protein expression as prognostic factor in human pancreatic cancer, Anticancer Res, 17, 2779

Tanaka, 1996, Evaluation of routine sonography for early detection of pancreatic cancer, Jpn J Clin Oncol, 26, 422, 10.1093/oxfordjournals.jjco.a023259

Numata, 2005, Contrast-enhanced sonography of pancreatic carcinoma: correlations with pathological findings, J Gastroenterol, 40, 631, 10.1007/s00535-005-1598-8

Tamburrino, 2016, Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer, Cochrane Database Syst Rev, 9, 10.1002/14651858.CD011515.pub2

Feldman, 2016, Imaging Evaluation of Pancreatic Cancer, Surg Clin North Am, 96, 1235, 10.1016/j.suc.2016.07.007

Hartwig, 2013, Improvement of surgical results for pancreatic cancer, Lancet Oncol, 14, e476, 10.1016/S1470-2045(13)70172-4

Finks, 2011, Trends in hospital volume and operative mortality for high-risk surgery, N Engl J Med, 364, 2128, 10.1056/NEJMsa1010705

Fong, 1995, Pancreatic or liver resection for malignancy is safe and effective for the elderly, Ann Surg, 222, 426, 10.1097/00000658-199522240-00002

Hatzaras, 2011, Pancreatic resection in the octogenarian: a safe option for pancreatic malignancy, J Am Coll Surg, 212, 373, 10.1016/j.jamcollsurg.2010.10.015

Turrini, 2013, Pancreatectomy for adenocarcinoma in elderly patients: postoperative outcomes and long term results: a study of the French Surgical Association, Eur J Surg Oncol, 39, 171, 10.1016/j.ejso.2012.08.017

Neoptolemos, 2001, Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial, Lancet, 358, 1576, 10.1016/S0140-6736(01)06651-X

Neoptolemos, 2017, Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial, Lancet, 10.1016/S0140-6736(16)32409-6

Gillen, 2010, Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages, PLoS Med, 7, 10.1371/journal.pmed.1000267

Barbas, 2012, Comparison of outcomes and the use of multimodality therapy in young and elderly people undergoing surgical resection of pancreatic cancer, J Am Geriatr Soc, 60, 344, 10.1111/j.1532-5415.2011.03785.x

Inouye, 1999, A multicomponent intervention to prevent delirium in hospitalized older patients, N Engl J Med, 340, 669, 10.1056/NEJM199903043400901

Brouquet, 2010, Impaired mobility, ASA status and administration of tramadol are risk factors for postoperative delirium in patients aged 75 years or more after major abdominal surgery, Ann Surg, 251, 759, 10.1097/SLA.0b013e3181c1cfc9

Chauffert, 2008, Ann Oncol, 19, 1592, 10.1093/annonc/mdn281

Hammel, 2016, Effect of chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial, JAMA, 315, 1844, 10.1001/jama.2016.4324

Ahlgren, 1999, Gastrointestinal cancer in the elderly, Gastroenterology, 15, 627

Chuong, 2013, Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated, Int J Radiat Oncol Biol Phys, 86, 516, 10.1016/j.ijrobp.2013.02.022

Tempero, 2003, Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma, J Clin Oncol, 21, 3402, 10.1200/JCO.2003.09.140

Locher, 2008, Fixed-dose rate gemcitabine in elderly patients with advanced pancreatic cancer: an observational study, Crit Rev Oncol Hematol, 68, 178, 10.1016/j.critrevonc.2008.06.010

Venook, 2000, Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565, J Clin Oncol, 18, 2780, 10.1200/JCO.2000.18.14.2780

Herrmann, 2007, Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group, J Clin Oncol, 25, 2212, 10.1200/JCO.2006.09.0886

Cunningham, 2009, Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer, J Clin Oncol, 27, 5513, 10.1200/JCO.2009.24.2446

Louvet, 2005, Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial, J Clin Oncol, 23, 3509, 10.1200/JCO.2005.06.023

Heinemann, 2006, Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer, J Clin Oncol, 24, 3946, 10.1200/JCO.2005.05.1490

Moore, 2007, Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group, J Clin Oncol, 25, 1960, 10.1200/JCO.2006.07.9525

Yamamoto, 2016, Tolerability and clinical outcomes in elderly patients with advanced pancreatic cancer treated with FOLFIRINOX, J Clin Oncol, 34

Alessandretti, 2013, Safety and efficacy of modified dose-attenuated FOLFIRINOX chemotherapy in patients over 65 years with advanced pancreatic adenocarcinoma, J Clin Oncol, 31, 10.1200/jco.2013.31.15_suppl.e15176

Blazer, 2014, Tolerability and efficacy of modified FOLFIRINOX (mFOLFIRINOX) in patients with borderline-resectable pancreatic cancer (BRPC) and locally advanced unresectable pancreatic cancer (LAURPC), J Clin Oncol, 32

Lichtman, 2007, International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients—an analysis of the medical literature, J Clin Oncol, 25, 1832, 10.1200/JCO.2007.10.6583

Ahn, 2017, A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis, Ther Adv Med Oncol, 9, 75, 10.1177/1758834016676011

Wang-Gillam, 2016, Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomized, open-label, phase 3 trial, Lancet, 387, 545, 10.1016/S0140-6736(15)00986-1

Clinical Trials.Gov

Bernabei, 1998, Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology, JAMA, 279, 1877, 10.1001/jama.279.23.1877

Sheehan, 1997, Symptomatic management of the older person with cancer, Clin Geriatr Med, 13, 203, 10.1016/S0749-0690(18)30190-3

Kaiko, 1982, Narcotics in the elderly, Med Clin North Am, 66, 1079, 10.1016/S0025-7125(16)31383-9

Puli, 2009, EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review, Dig Dis Sci, 54, 2330, 10.1007/s10620-008-0651-x

van den Bosch, 1994, Guidelines for the application of surgery and endoprostheses in the palliation of obstructive jaundice in advanced cancer of the pancreas, Ann Surg, 219, 18, 10.1097/00000658-199401000-00004

Giovannini, 2001, Endoscopic ultrasound-guided bilioduodenal anastomosis: a new technique for biliary drainage, Endoscopy, 33, 898, 10.1055/s-2001-17324

Maetani, 2009, Metallic stents for gastric outlet obstruction: reintervention rate is lower with uncovered versus covered stents, despite similar outcomes, Gastrointest Endosc, 69, 806, 10.1016/j.gie.2008.06.009